CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.37B | 1.37B | 1.35B | 1.33B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.37B | 1.37B | 1.35B | 1.33B |
| Cost of Revenue | 617.95M | 632.84M | 639.35M | 591.54M | 580.84M |
| Gross Profit | 753.71M | 737.67M | 735.38M | 755.94M | 745.41M |
| SG&A Expenses | 545.46M | 542.21M | 553.62M | 550.65M | 538.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.22B | 1.23B | 1.25B | 1.20B | 1.17B |
| Operating Income | 147.62M | 136.19M | 125.87M | 151.12M | 153.16M |
| Income Before Tax | 83.23M | 81.80M | 71.12M | 85.51M | 137.69M |
| Income Tax Expenses | 26.73M | 26.95M | 24.06M | 21.44M | 27.49M |
| Earnings from Continuing Operations | 56.50 | 54.85 | 47.06 | 64.07 | 110.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.50M | 54.85M | 47.06M | 64.07M | 110.20M |
| EBIT | 147.62M | 136.19M | 125.87M | 151.12M | 153.16M |
| EBITDA | 221.76M | 209.86M | 198.95M | 223.16M | 224.56M |
| EPS Basic | 1.85 | 1.78 | 1.52 | 2.07 | 3.57 |
| Normalized Basic EPS | 2.46 | 2.14 | 1.90 | 2.39 | 2.40 |
| EPS Diluted | 1.85 | 1.77 | 1.51 | 2.05 | 3.53 |
| Normalized Diluted EPS | 2.45 | 2.13 | 1.89 | 2.37 | 2.38 |
| Average Basic Shares Outstanding | 122.58M | 123.46M | 123.85M | 123.80M | 123.70M |
| Average Diluted Shares Outstanding | 122.82M | 123.76M | 124.29M | 124.40M | 124.46M |
| Dividend Per Share | 0.20 | 0.40 | 0.60 | 0.80 | 0.80 |
| Payout Ratio | 21.91% | 33.85% | 52.59% | 38.60% | 22.42% |